Clinical and Translational Science Collaborative of Cleveland
Clinical and Translational Science Collaborative of Cleveland
批准号:
9093875
负责人:
MICHAEL W. KONSTAN
金额:
$977.48万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-17 至 2018-05-31
关键词:
AmericasChild health careCitiesClinicClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunitiesDatabasesDevelopmentDiagnosticElectronic Health RecordElectronicsEvaluationFocus GroupsGoalsGrantHealthHealth PrioritiesHome environmentHumanInformaticsInstitutionInstitutional Review BoardsInstructionLaboratoriesMalignant NeoplasmsMedicalMedical centerNeedlesNeighborhoodsOhioPatientsResearchResearch InfrastructureResource SharingResourcesSiteSupport SystemTestingTherapeuticTranslational ResearchTranslationsUnited States Department of Veterans AffairsUniversitiesUniversity Hospitalsbasecommunity partnershipdata sharingdiabeticimprovedmanoperationoptimismpractice-based research networkprototypescreeningtherapeutic targettoolweb siteweb-based informatics
中文摘要
克利夫兰临床与转化科学合作中心(CTSC)是由克利夫兰大学的
英文摘要
The Clinical and Translational Science Collaborative (CTSC) of Cleveland is a collaborative venture among
five Cleveland health institutions - Case Western Reserve University, the Cleveland Clinic, University
Hospitals, MetroHealth Medical Center, and the Veterans Administration Medical Center, as well as
community partners. CTSC achieved prior goals of uniting as a collaborative, developed informatics tools,
resource sharing, and institutional commitments to enhance the collaborative. Consolidation and catalytic
activities begun in the last grant period will be continued. Moreover, CTSC will continue rigorous evaluation
of both its operations and progress toward larger goals. CTSC has set three new goals for the next grant
period. 1) Translation 1 research will be enhanced. Infrastructure in support of identification and structural
determination of therapeutic targets, as well as high through put screening will be implemented. Support
systems to assist in patient based research both recruitment and testing will be streamlined and
strengthened. Critically, CTSC will create support systems to guide development of potential human
therapeutics and diagnostics from discovery to use in man, 2) CTSC will improve health parameters in
Cleveland, one of America's poorest and least healthy cities. Community Research Partnership Core is
querying the community via neighborhood focus groups to determine their health priorities. At least one of
these priorities, and others selected based on the strengths of our CTSC investigative community, will be
targeted for special effort. One practice based research network has already succeeded in reducing HgbAlc
in 27,000 diabetics in Cleveland by one percentage point in three years, raising optimism that this project
can indeed move the needle. 3) CTSC interactions with the national CTSA community will increase. The
initial focus of CTSC was inward, establishing connections and catalyzing change in our home institutions,
but in the next grant period the CTSC will increase interactions around the consortium. A primary focus will
be the Ohio Consortium ofthe three Ohio CTSAs (CTSC, Columbus, Cincinnati), which currently collaborate
surrounding child health and cancer projects, and on the web site NetWellness, which has been expanded
from simply providing unbiased medical information to include descriptions of clinical research and access to
clinical trials. In the next grant period goals will include extending the CTSC IRB electronic hub for facilitated
review to include the other CTSA sites, increasing project collaboration, and connecting patient databases
via Explorys, a web based informatics tool utilizing the electronic health record.
RELEVANCE (See instructions):
The CTSC is highly relevant to human health. Using the Cleveland biomedical community as a prototype,
we will develop and test electronic and other strategies for coordinating research functions among different
institutions, such as IRB approval and facile data sharing. Using the Cleveland community as a laboratory
and our practice based research networks and community partnership resource as tools, we will seek to
improve health parameters in Cleveland. We will also develop more facile means for Translation 1.
期刊论文(96)
专著(0)
科研奖励(0)
会议论文
Reply.
回复。
DOI:
10.1002/art.40923
发表时间:
2019
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
[Kim,AlfredHJ, Strand,Vibeke, Atkinson,JohnP]
通讯作者:
Atkinson,JohnP
A metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancer.
一种含金属核苷,具有抗癌治疗和诊断活性。
DOI:
10.1074/jbc.m114.620294
发表时间:
2015
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Choi,Jung-Suk, Maity,Ayan, Gray,Thomas, Berdis,AnthonyJ]
通讯作者:
Berdis,AnthonyJ
Clinical and Translational Science Collaborative of Cleveland
-
批准号:9978966
-
项目类别:
-
资助金额:$672.2万
-
财政年份:2018
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Research Career Development in Child Health
-
批准号:7994220
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2008
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Research Career Development in Child Health
-
批准号:8197139
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2008
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical and Translational Science Collaborative of Cleveland
-
批准号:9093876
-
项目类别:
-
资助金额:$222.31万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical Studies
-
批准号:7288639
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
-
批准号:7378077
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2006
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
BIIL284BS IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS
-
批准号:7202776
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
ORAL THERACLEC-TOTAL IN CF PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
-
批准号:7202793
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
TOBRAMYCIN FOR INHALATION (TOBI) IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
-
批准号:7202765
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
BIIL284BS in adult and pediatric cystic fibrosis patients
-
批准号:6974994
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Oral TheraCLEC-Total in adult and pediatric subjects with cystic fibrosis
-
批准号:6974986
-
项目类别:
-
资助金额:$6.21万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Fat and protein absorption in cystic fibrosis pts with pancreatic insufficiency
-
批准号:6975001
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Neutrophil imaging of the lung for characterizing pulmonary infection in CF pts
-
批准号:6974990
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6301071
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2000
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
LUNG SPECIFIC BIOEFFICACY OF ORAL DMP 777 IN ADULTS W/ CF
-
批准号:6305356
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6201835
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
CPX (ORAL, MULTIDOSE) IN ADULTS W/ MILD TO MODERATELY SEVERE CYSTIC F
-
批准号:6305371
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
CPX (ORAL, MULTIDOSE) IN ADULTS W/ MILD TO MODERATELY SEVERE CYSTIC F
-
批准号:6264431
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6105187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
DMP777 IN ADULT PATIENTS 18 YRS OF AGE AND OLDER WITH CYSTIC FIBROSIS
-
批准号:6115324
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
海外基金